Arabinosylcytosine

The patients undergoing haploidentical HSCT were conditioned with 9.0–10.5 Gy TBI on days −7 and −6, 6 g/m 2 /day intravenous arabinosylcytosine (Ara-C) on days −5 to −3, 45 mg/kg/day intravenous CY on days −3 to −2, and 2.5 mg/kg/day intravenous anti-thymocyte globulin (ATG) (Sanofi, SangStat, Lyon, France) on days −5 to −2.